|
US6495518B1
(en)
|
1994-06-13 |
2002-12-17 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
US7553929B2
(en)
*
|
1994-06-13 |
2009-06-30 |
Vanderbilt University |
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
|
|
FR2739621B1
(fr)
*
|
1995-10-05 |
1997-12-05 |
Centre Nat Rech Scient |
Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
|
|
US5962415A
(en)
*
|
1996-09-20 |
1999-10-05 |
Bristol-Myers Squibb Co. |
Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
|
|
GB2337329B
(en)
*
|
1997-04-30 |
2001-09-05 |
Imp Cancer Res Tech |
Inhibitors of nuclear protein/nuclear receptor interaction
|
|
GB9708676D0
(en)
*
|
1997-04-30 |
1997-06-18 |
Imp Cancer Res Tech |
Chemical compounds
|
|
AU766489B2
(en)
*
|
1998-11-13 |
2003-10-16 |
Cyclacel Limited |
Transport vectors
|
|
AU5011200A
(en)
*
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in hematopoietic cells
|
|
ATE385503T1
(de)
|
1999-06-28 |
2008-02-15 |
Inter K Pty Ltd |
Verfahren zur modulierung von integrin- vermittelter zellaktivitaet und hierfuer geeignete reagenzien
|
|
DE19933492B4
(de)
*
|
1999-07-16 |
2008-01-10 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
|
|
US6312956B1
(en)
*
|
1999-10-01 |
2001-11-06 |
Vanderbilt University |
Nuclear targeted peptide nucleic acid oligomer
|
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6844324B1
(en)
*
|
1999-11-12 |
2005-01-18 |
Massachusetts Institute Of Technology |
Modular peptide mediated intracellular delivery system and uses therefore
|
|
EP1235914A2
(en)
*
|
1999-11-24 |
2002-09-04 |
Joseph Rosenecker |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
EP1862471A3
(en)
*
|
2000-02-07 |
2008-05-28 |
Wisconsin Alumni Research Foundation |
Pharmacologically active antiviral peptides and methods of their use
|
|
JP4896333B2
(ja)
*
|
2000-02-07 |
2012-03-14 |
ウイスコンシン アラムニ リサーチ ファンデーション |
薬理活性抗ウイルスペプチドおよびそれらの使用法
|
|
GB0103110D0
(en)
|
2000-08-25 |
2001-03-28 |
Aventis Pharma Inc |
A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1
|
|
US20040086896A1
(en)
*
|
2001-04-19 |
2004-05-06 |
Julie Carman |
Polynucleotides and polypeptides associated with the NF-kB pathway
|
|
AU2002252705A1
(en)
*
|
2001-04-19 |
2002-11-05 |
Bristol-Myers Squibb Company |
Polynucleotides and polypeptides associated with the nf-kb pathway
|
|
ATE489462T1
(de)
*
|
2002-04-25 |
2010-12-15 |
Toagosei Co Ltd |
Antimikrobielles polypeptid und nutzung davon
|
|
EP2418219B1
(en)
*
|
2003-10-17 |
2018-06-27 |
InterK Peptide Therapeutics Limited |
Methods and agents for the treatment of cancer
|
|
US7674771B2
(en)
*
|
2003-10-29 |
2010-03-09 |
Toagosei Co., Ltd |
Antimicrobial peptides and utilization of the same
|
|
WO2005060541A2
(en)
*
|
2003-12-01 |
2005-07-07 |
Wisconsin Alumni Research Foundation |
Peptides and methods for inducing cellular resistance to infection
|
|
US20050203150A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Haffar Omar K. |
Compounds, compositions and methods for inhibiting or treating HIV-1
|
|
JP4507080B2
(ja)
*
|
2004-07-30 |
2010-07-21 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
|
WO2006056227A1
(en)
*
|
2004-11-27 |
2006-06-01 |
Eberhard-Karls- Universität Tübingen Universitätsklinikum |
Conjugates comprising the active agent and flanking or branched-chain peptides
|
|
JP4730584B2
(ja)
|
2004-12-06 |
2011-07-20 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
|
US20090030179A1
(en)
*
|
2005-02-15 |
2009-01-29 |
Toagosei Co., Ltd |
Antimicrobial peptide and use thereof
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20110105408A1
(en)
*
|
2008-02-22 |
2011-05-05 |
Inter-K Pty Limited |
Therapeutic peptides
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
JP2012533521A
(ja)
|
2008-07-17 |
2012-12-27 |
ニュートリペップ・ピーティーワイ・リミテッド |
治療剤
|
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
WO2012048721A1
(en)
|
2010-10-14 |
2012-04-19 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
KR20160023669A
(ko)
|
2013-06-26 |
2016-03-03 |
자이겐 인플라메이션 리미티드 |
다양한 질병의 치료를 위한 jnk 신호 전달 경로의 세포 투과성 펩타이드 억제자의 새로운 용도
|
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
HUE049292T2
(hu)
|
2013-08-07 |
2020-09-28 |
Yeda Res & Dev |
A P53 mutánsok újraaktíválására képes peptidek
|
|
KR20150050646A
(ko)
*
|
2013-10-29 |
2015-05-11 |
삼성전자주식회사 |
융합 펩타이드 및 이의 세포막투과를 위한 용도
|
|
CN108884137B
(zh)
*
|
2016-02-04 |
2022-04-05 |
耶达研究及发展有限公司 |
肽及其在治疗与突变型p53相关的疾病、病症或病况中的用途
|
|
BR112022011744A2
(pt)
*
|
2020-02-18 |
2022-09-20 |
Cellivery Therapeutics Inc |
Peptídeo sintético inibidor de importação nuclear permeável à célula melhorado para inibição de tempestade de citocina ou doença inflamatória e uso do mesmo
|